US electronic records: devices sector "not disadvantaged"
This article was originally published in Clinica
Industry officials are relieved that the FDA's new draft guidance on the interpretation of Part 11 rules regarding electronic records does not contain a pharmaceutical bias that could be damaging to the devices industry.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.